Antibiotic use in US hospitals: Quantification, quality measures and stewardship

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 7, 2015, Pages 843-854

  Reddy, Sujan C ^a,b   Jacob, Jesse T ^a   Varkey, Jay B ^a   Gaynes, Robert P ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

antimicrobial stewardship; appropriate use; benchmarking

Indexed keywords

BETA LACTAM; C REACTIVE PROTEIN; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN; LEVOFLOXACIN; METRONIDAZOLE; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; QUINOLONE DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIURIA; COMMUNITY ACQUIRED PNEUMONIA; DRUG COST; DRUG INFORMATION; DRUG USE; DRUG UTILIZATION; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; INAPPROPRIATE PRESCRIBING; LENGTH OF STAY; MAINTENANCE THERAPY; NONHUMAN; PATIENT SAFETY; PNEUMONIA; POINT OF CARE TESTING; PRESCRIPTION; PREVALENCE; REVIEW; TREATMENT DURATION; UNITED STATES; URINARY TRACT INFECTION; HOSPITAL; PROCEDURES; QUALITY CONTROL; STANDARDS;

ANTI-BACTERIAL AGENTS; BENCHMARKING; DRUG UTILIZATION; HOSPITALS; HUMANS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 84931067474     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1040766     Document Type: Review

References (66)

1. Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014; 63: 194-200
2. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77
3. Executive Order No 13676. Fed Regist 2014; 184(79): 56931-5
4. Food and Drug Administration. 2011 summary report on antimicrobials sold or distributed for use in food-producing animals. Available from: www.fda.gov/downloads/forindustry/userfees/animaldruguserfeeactadufa/ucm338170.pdf [Last accessed 29 March 2015]
5. Polk RE, Fox C, Mahoney A, et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007; 44: 664-70
6. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-52
7. Pakyz AL, MacDougall C, Oinonen M, Polk RE. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med 2008; 168: 2254-60
8. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-Adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011; 53: 1100-10
9. Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis 2014; 58: 401-6
10. Magill SS, Edwards JR, Beldavs ZG, et al. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA 2014; 312: 1438-46
11. Charani E, Castro-Sanchez E, Sevdalis N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of prescribing etiquette. Clin Infect Dis 2013; 57: 188-96
12. Kariv G, Paul M, Shani V, et al. Benchmarking inappropriate empirical antibiotic treatment. Clin Microbiol Infect 2013; 19: 629-33
13. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther 2012; 10: 445-57
14. Aldeyab MA, McElnay JC, Scott MG, et al. A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking. J Antimicrob Chemother 2014; 69: 1132-41
15. Monnet DL, Archibald LK, Phillips L, et al. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998; 19: 388-94
16. Centers for Disease Control and Prevention. CDC's campaign to prevent antimicrobial resistance in health-care settings. MMWR Morb Mortal Wkly Rep 2002; 51: 343
17. Jenkins TC, Stella SA, Cervantes L, et al. Targets for antibiotic and healthcare resource stewardship in inpatient community-Acquired pneumonia: a comparison of management practices with National Guideline Recommendations. Infection 2013; 41: 135-44
18. Braykov NP, Morgan DJ, Schweizer ML, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis 2014; 14: 1220-7
19. Huang AM, Newton D, Kunapuli A, et al. Impact of rapid organism identification via matrix-Assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 2013; 57: 1237-45
20. Tamma PD, Tan K, Nussenblatt VR, et al. Can matrix-Assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF) enhance antimicrobial stewardship efforts in the acute care setting? Infect Control Hosp Epidemiol 2013; 34: 990-5
21. Avdic E, Carroll KC. The role of the microbiology laboratory in antimicrobial stewardship programs. Infect Dis Clin North Am 2014; 28: 215-35
22. Werner NL, Hecker MT, Sethi AK, Donskey CJ. Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC Infect Dis 2011; 11: 187
23. Jones M, Huttner B, Madaras-Kelly K, et al. Parenteral to oral conversion of fluoroquinolones: low-hanging fruit for antimicrobial stewardship programs? Infect Control Hosp Epidemiol 2012; 33: 362-7
24. Weston G, Jacob JT, Ray S, et al. A multicenter study measuring appropriateness of carbapenem use. Infect Control Hosp Epidemiol 2013; 34: 1324-6
25. Anderson DJ, Moehring RW, Sloane R, et al. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. PLoS One 2014; 9: e91713
26. Available from: www.idsociety.org/idsa-practice-guidelines/
27. Becher RD, Hoth JJ, Rebo JJ, et al. Locally derived versus guideline-based approach to treatment of hospital-Acquired pneumonia in the trauma intensive care unit. Surg Infect (Larchmt) 2012; 13: 352-9
28. Huttner B, Jones M, Rubin MA, et al. Double trouble: how big a problem is redundant anaerobic antibiotic coverage in Veterans Affairs medical centres? J Antimicrob Chemother 2012; 67: 1537-9
29. Schultz L, Lowe TJ, Srinivasan A, et al. Economic impact of redundant antimicrobial therapy in US hospitals. Infect Control Hosp Epidemiol 2014; 35: 1229-35
30. Hayashi Y, Paterson DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis 2011; 52: 1232-40
31. Tobia CC, Aspinall SL, Good CB, et al. Appropriateness of antibiotic prescribing in veterans with community-Acquired pneumonia, sinusitis, or acute exacerbations of chronic bronchitis: a cross-sectional study. Clin Ther 2008; 30: 1135-44
32. van den Bosch CM, Geerlings SE, Natsch S, et al. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis 2015; 60: 281-91
33. Get Smart for Healthcare: Implementation Resources. 2015. Available from: http://www.cdc.gov/getsmart/healthcare/implementation.html. [Accessed 25 February 2015]
34. Griffith M, Postelnick M, Scheetz M. Antimicrobial stewardship programs: methods of operation and suggested outcomes. Expert Rev Anti Infect Ther 2012; 10: 63-73
35. Scheetz MH, Bolon MK, Postelnick M, et al. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother 2009; 63: 816-25
36. Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am 2014; 28: 195-214
37. Sick AC, Lehmann CU, Tamma PD, et al. Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program. Infect Control Hosp Epidemiol 2013; 34: 573-80
38. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24: 471-85
39. Standiford HC, Chan S, Tripoli M, et al. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol 2012; 33: 338-45
40. Donabedian A, Wheeler JR, Wyszewianski L. Quality, cost, and health: an integrative model. Med Care 1982; 20: 975-92
41. Jacob JT, Gaynes RP. Emerging trends in antibiotic use in US hospitals: quality, quantification and stewardship. Expert Rev Anti Infect Ther 2010; 8: 893-902
42. Kaki R, Elligsen M, Walker S, et al. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 2011; 66: 1223-30
43. Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 33: 1462-8
44. Evans RS, Pestotnik SL, Classen DC, et al. A computer-Assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338: 232-8
45. Feazel LM, Malhotra A, Perencevich EN, et al. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-Analysis. J Antimicrob Chemother 2014; 69: 1748-54
46. Du B, Chen D, Liu D, et al. Restriction of third-generation cephalosporin use decreases infection-related mortality. Crit Care Med 2003; 31: 1088-93
47. Pulcini C, Botelho-Nevers E, Dyar OJ, Harbarth S. The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect 2014; 20: 963-72
48. Ntagiopoulos PG, Paramythiotou E, Antoniadou A, et al. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece. Int J Antimicrob Agents 2007; 30: 360-5
49. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013(4): CD003543
50. Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am 2014; 28: 177-93
51. Solomon DH, Van Houten L, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001; 161: 1897-902
52. Hamilton KW, Fishman NO. Antimicrobial stewardship interventions: thinking inside and outside the box. Infect Dis Clin North Am 2014; 28: 301-13
53. Masterton RG. Antibiotic de-escalation. Crit Care Clin 2011; 27: 149-62
54. Goff DA, Jankowski C, Tenover FC. Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy 2012; 32: 677-87
55. Hopstaken RM, Muris JW, Knottnerus JA, et al. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003; 53: 358-64
56. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-Analysis. Clin Infect Dis 2004; 39: 206-17
57. Salluh JI, Nobre V, Povoa P. Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers. Crit Care 2014; 18: 142
58. Shehabi Y, Sterba M, Garrett PM, et al. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med 2014; 190: 1102-10
59. Jamoom E, Beatty P, Bercovitz A, et al. Physician adoption of electronic health record systems: United States, 2011. NCHS Data Brief 2012; 1-8
60. Kullar R, Goff DA. Transformation of antimicrobial stewardship programs through technology and informatics. Infect Dis Clin North Am 2014; 28: 291-300
61. Forrest GN, Van Schooneveld TC, Kullar R, et al. Use of electronic health records and clinical decision support systems for antimicrobial stewardship. Clin Infect Dis 2014; 59(Suppl 3): S122-33
62. Gaynes RP, Gould CV, Edwards J, et al. A multicenter study on optimizing piperacillin-Tazobactam use: lessons on why interventions fail. Infect Control Hosp Epidemiol 2009; 30: 794-6
63. Perencevich EN, Stone PW, Wright SB, et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007; 28: 1121-33
64. Bannan A, Buono E, McLaws ML, Gottlieb T. A survey of medical staff attitudes to an antibiotic approval and stewardship programme. Intern Med J 2009; 39: 662-8
65. Gaynes RP. Preserving the effectiveness of antibiotics. JAMA 2010; 303: 2293-4
66. Boucher HW, Talbot GH, Benjamin DK Jr, et al. 10 x '20 Progress-development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 2013; 56: 1685-94